SOZO vs AI Platform

Exo Imaging's AI Platform, particularly with the Exo Iris device, is designed for simplicity and immediate answers, enabling even novice users to get instant results. Its SweepAIu2122 technology automatically acquires images, reducing operator dependence and bias, and the AI Scan Tutor and anatomical labeling further enhance ease of use. SOZO also emphasizes ease of use with a rapid 30-second scan and intuitive touchscreen, but Exo's AI-guided imaging for novice users gives it an edge in overall usability.

Exo Imaging's AI Platform offers real-time AI for ultrasound image assessment across multiple specialties like cardiology and pulmonology, with FDA-cleared AI for detecting pleural effusion and consolidation/atelectasis, and validated improved accuracy in lung ultrasound interpretation. SOZO is highly effective for lymphedema detection and management, with clinical trials showing a 92% reduction in progression to chronic lymphedema. However, Exo's broader application of real-time AI across diverse and critical diagnostic areas, coupled with its proven impact on diagnostic accuracy, provides a slightly higher clinical value.

Exo Imaging provides transparent pricing for its Iris Essential Package, including the device and a mandatory annual subscription for Exo Works after the first year, with flexible deployment options including a subscription-free model. While SOZO operates on a SaaS model with no-cost software upgrades, specific pricing details are not publicly available. Exo's clear pricing structure and flexible subscription options offer better transparency and potentially more adaptable value for different clinical settings.

SOZO by ImpediMed has a strong track record with over 1,100 devices in use globally and over 500,000 patient tests performed, indicating robust scalability and adoption within health systems. It also features cloud-based data management, automated reporting, and EHR interface capabilities, supporting large-scale deployments. While Exo Imaging also offers cloud-based deployment and integration with PACS/DICOM, SOZO's extensive existing customer base and proven widespread implementation suggest a higher degree of enterprise readiness.

Exo Imaging's AI Platform integrates real-time AI directly with handheld ultrasound devices, offering features like SweepAI for guided view capture and automated findings, which represents a significant innovation in point-of-care imaging. SOZO's bioimpedance spectroscopy (BIS) technology is also innovative for lymphedema and fluid status assessment, but Exo's application of AI to real-time ultrasound imaging across multiple diagnostic areas pushes the boundaries of current medical imaging technology.

Both tools offer comprehensive support and documentation. ImpediMed provides a support center with FAQs, IFU documents, help videos, and direct contact options for customer and technical support across different regions. Exo Imaging also offers a support center with user manuals, release notes, and contact information via email and phone. Both companies appear to provide adequate resources for user assistance, making it difficult to distinguish a clear winner.